Skip to content

BIOMEDICAL DIAGNOSTICS

Active
Public limited companyfounded 2003active for 23 yearsNoorderlaan 139, 2030 Antwerpen, BelgiumKBO/BCE: BE 0479.414.976

Financials · financial year 2025, full format

Annual accounts 2025 filed on 19-06-2026 at the NBB all 22 filings

Turnover
≈ €5.5m
Estimated: probably between €3.3m and €9.3m
EBIT margin
Not included in this filing
Net result
€339,858▼ 10.1%
2024 · €378,092
Working capital
€2.4m▲ 11.8%
2024 · €2.1m
Multi-year overview
2018 to 2025, 8 financial years
Operating result
€401,512
▼ 11.4% 2025
20182025
Net result
€339,858
▼ 10.1% 2025
middle half of the sector
20182025
Equity
€2.5m
▲ 16.0% 2025
middle half of the sector
20182025
Total assets
€3.5m
▲ 16.9% 2025
middle half of the sector
20182025
Debt
€1.0m
▲ 26.0% 2025
20182025
Working capital
€2.4m
▲ 11.8% 2025
middle half of the sector
20182025
Solvency
70.2%
▼ 0.6pp 2025
highest quarter of the sector
20182025
Current ratio
3.27
▼ 0.29 2025
highest quarter of the sector
20182025
Return on assets (ROA)
9.7%
▼ 2.9pp 2025
highest quarter of the sector
20182025
Staff (FTE)
7.4
▲ 10.4% 2025
middle half of the sector
20182025
Every figure per financial year
Every figure with its change against the financial year before
favourable unfavourable
Line20182019202020212022202320242025
Operating result€0.8m-€0.7m▼ 16.8%€0.6m▼ 19.8%€0.6m▲ 12.1%€0.9m▲ 45.0%€0.7m▼ 20.9%€0.5m▼ 37.8%€0.4m▼ 11.4%
Net result€0.8m-€0.6m▼ 24.9%€0.5mabove the sector's middle half▼ 14.9%€0.5mabove the sector's middle half▼ 1.9%€0.6mabove the sector's middle half▲ 20.4%€0.6mabove the sector's middle half▲ 2.2%€0.4mabove the sector's middle half▼ 37.3%€0.3mwithin the sector's middle half▼ 10.1%
Equity€0.8m-€0.9m▲ 16.2%€0.5mwithin the sector's middle half▼ 44.0%€0.6mwithin the sector's middle half▲ 9.4%€1.1mabove the sector's middle half▲ 106%€1.8mabove the sector's middle half▲ 52.5%€2.1mabove the sector's middle half▲ 21.6%€2.5mwithin the sector's middle half▲ 16.0%
Total assets€1.9m-€1.8m▼ 2.8%€1.8mwithin the sector's middle half=€1.7mwithin the sector's middle half▼ 9.5%€1.7mwithin the sector's middle half▲ 1.2%€2.6mwithin the sector's middle half▲ 53.6%€3.0mabove the sector's middle half▲ 16.0%€3.5mwithin the sector's middle half▲ 16.9%
Debt€1.1m-€0.9m▼ 17.0%€1.3m▲ 45.4%€1.1m▼ 17.2%€0.5m▼ 53.5%€0.8m▲ 61.2%€0.8m▲ 4.5%€1.0m▲ 26.0%
Working capital€0.8m-€0.9m▲ 16.9%€0.5mwithin the sector's middle half▼ 49.6%€0.5mwithin the sector's middle half▲ 15.9%€1.0mabove the sector's middle half▲ 98.6%€1.7mabove the sector's middle half▲ 66.8%€2.1mabove the sector's middle half▲ 21.4%€2.4mwithin the sector's middle half▲ 11.8%
Solvency41.3%-49.4%▲ 8.1pp27.7%within the sector's middle half▼ 21.7pp33.4%within the sector's middle half▲ 5.8pp67.9%above the sector's middle half▲ 34.5pp67.5%above the sector's middle half▼ 0.5pp70.7%above the sector's middle half▲ 3.3pp70.2%above the sector's middle half▼ 0.6pp
Current ratio1.73-2.02▲ 0.301.35within the sector's middle half▼ 0.671.50within the sector's middle half▲ 0.143.18above the sector's middle half▲ 1.683.27above the sector's middle half▲ 0.093.56above the sector's middle half▲ 0.303.27above the sector's middle half▼ 0.29
Return on assets (ROA)41.1%-31.8%▼ 9.3pp27.1%above the sector's middle half▼ 4.7pp29.4%above the sector's middle half▲ 2.3pp34.9%above the sector's middle half▲ 5.6pp23.2%above the sector's middle half▼ 11.7pp12.6%above the sector's middle half▼ 10.7pp9.7%above the sector's middle half▼ 2.9pp
Staff (FTE)7-6.2▼ 11.4%5.9within the sector's middle half▼ 4.8%5.7within the sector's middle half▼ 3.4%5.3within the sector's middle half▼ 7.0%5.8within the sector's middle half▲ 9.4%6.7within the sector's middle half▲ 15.5%7.4within the sector's middle half▲ 10.4%
above within below The sector band is the middle half of the companies in Wholesale trade (NACE 46). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.

The operating result for 2025 is 11% lower than in 2024 and the lowest since 2021. It is the third fall in a row.

The turnover shown is an estimate from the gross margin.

Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €3.5m
Fixed assets €102,889 ▲ 65.3%
Current assets €3.4m ▲ 15.9%
Equity and liabilities €3.5m
Equity €2.5m ▲ 16.0%
Provisions €0 ▼ 100%
Debt €1.0m ▲ 26.0%
Debt's share of the balance-sheet total rises from 27.7% to 29.8%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€425,968▼
2024 · €472,976
Cash flow
€364,314▼
2024 · €397,862
Quick ratio
2.41▼
2024 · 3.02
Debt to equity
0.42▲
2024 · 0.39
ROE
13.8%▼
2024 · 17.8%
Interest coverage
49.93▲
2024 · 22.76
Debt ≤ 1 year
€1.0m▲
2024 · €827,698
Income taxes
€122,269▼
2024 · €134,267
Staff costs
€949,521▲
2024 · €840,471
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.

Staff

social balance sheet
Item31-12-202131-12-202231-12-202331-12-202431-12-2025
Employees at the balance-sheet date677810
full-time34456
part-time33334
in full-time equivalents4.95.95.96.98.4
Average over the year, in full-time equivalents5.75.35.86.77.4
On a permanent contract677810
Joined01-13
Left11-01

Source: social balance sheet in the 2021 to 2025 annual accounts

Investments

fixed assets acquired
Item20212022202320242025
Tangible fixed assets€20,800€123,271€15,558€29,900€72,642
Financial fixed assets--€34€60€60
Depreciation and write-downs of the year€20,632€30,174€21,244€19,771€24,455

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 55 lines
Balance sheet Code20242025
Assets
Total assets20/58€3.0m€3.5m▲
Fixed assets21/28€0.06m€0.1m▲
Tangible fixed assets22/27€0.05m€0.09m▲
Plant, machinery and equipment23€0.05m€0.09m▲
Financial fixed assets28€0.01m€0.01m▲
Current assets29/58€2.9m€3.4m▲
Stocks and contracts in progress3€0.4m€0.9m▲
Stocks30/36€0.4m€0.9m▲
Amounts receivable within one year40/41€1.8m€2.0m▲
Trade receivables40€0.7m€0.9m▲
Other amounts receivable41€1.1m€1.1m▲
Cash at bank and in hand54/58€0.7m€0.5m▼
Deferred charges and accrued income490/1€0.02m€0.004m▼
Equity and liabilities
Total equity and liabilities10/49€3.0m€3.5m▲
Equity10/15€2.1m€2.5m▲
Contributions10/11€0.06m€0.06m=
Capital10€0.06m€0.06m=
Issued capital100€0.06m€0.06m=
Reserves13€2.1m€2.4m▲
Non-distributable reserves130/1€0.006m€0.006m=
Legal reserve130€0.006m€0.006m=
Distributable reserves133€2.1m€2.4m▲
Provisions and deferred taxes16€0.05m-
Provisions for liabilities and charges160/5€0.05m-
Other liabilities and charges164/5€0.05m-
Amounts payable17/49€0.8m€1.0m▲
Amounts payable within one year42/48€0.8m€1.0m▲
Trade debts44€0.6m€0.8m▲
Suppliers440/4€0.6m€0.8m▲
Taxes, remuneration and social security45€0.2m€0.2m▼
Taxes450/3€0.1m€0.09m▼
Remuneration and social security454/9€0.1m€0.1m▼
Other amounts payable47/48€0.001m€0.001m=
Accrued charges and deferred income492/3€0.005m€0.005m▲
Income statement Code20242025
Non-recurring operating income76A€0.02m€0.005m▼
Remuneration, social security and pensions62€0.8m€0.9m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.02m€0.02m▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€0.02m-€0.03m▼
Provisions for liabilities and charges: additions (uses and reversals)635/8--€0.05m
Other operating charges640/8€0.004m€257▼
Non-recurring operating charges66A€0.04m€0.008m▼
Gross operating margin9900€1.4m€1.3m▼
Operating profit (loss)9901€0.5m€0.4m▼
Financial income75/76B€0.08m€0.07m▼
Recurring financial income75€0.08m€0.07m▼
Financial charges65/66B€0.02m€0.009m▼
Recurring financial charges65€0.02m€0.009m▼
Profit (loss) for the period before taxes9903€0.5m€0.5m▼
Income taxes67/77€0.1m€0.1m▼
Profit (loss) for the period9904€0.4m€0.3m▼
Profit (loss) for the period to be appropriated9905€0.4m€0.3m▼
Appropriation of the result
Profit (loss) to be appropriated9906€0.4m€0.3m▼
Transfer to equity691/2€0.4m€0.3m▼
To other reserves6921€0.4m€0.3m▼
Social balance sheet
Average headcount (FTE)90876.77.4▲

The notes to these accounts have 10 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 19-06-2026.

Line20182019202020212022202320242025Change
Non-recurring operating income76A---€0.09m€0.03m€0.04m€0.02m€0.005m▼ 71.5%
Remuneration, social security and pensions62---€0.7m€0.6m€0.7m€0.8m€0.9m▲ 13.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.04m€0.05m€0.03m€0.02m€0.03m€0.02m€0.02m€0.02m▲ 23.7%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4---€0.002m-€0.001m-€0.001m€0.02m-€0.03m-
Provisions for liabilities and charges: additions (uses and reversals)635/8----€0.003m----€0.05m-
Other operating charges640/8---€0.001m€0.001m€0.002m€0.004m€257▼ 93.4%
Non-recurring operating charges66A-----€0.001m€0.04m€0.008m▼ 79.5%
Gross operating margin9900€1.5m€1.4m€1.2m€1.3m€1.5m€1.4m€1.4m€1.3m▼ 4.9%
Operating profit (loss)9901€0.8m€0.7m€0.6m€0.6m€0.9m€0.7m€0.5m€0.4m▼ 11.4%
Financial income75/76B---€0.04m€0.002m€0.08m€0.08m€0.07m▼ 13.5%
Recurring financial income75€0.02m€0.002m€0.02m€0.04m€0.002m€0.08m€0.08m€0.07m▼ 13.5%
Financial charges65/66B---€0.007m€0.1m-€233€0.02m€0.009m▼ 59.0%
Recurring financial charges65€0.02m€0.07m€0.05m€0.007m€0.1m-€233€0.02m€0.009m▼ 59.0%
Profit (loss) for the period before taxes9903€0.8m€0.6m€0.5m€0.7m€0.8m€0.8m€0.5m€0.5m▼ 9.8%
Income taxes67/77€0.06m€0.06m€0.04m€0.2m€0.2m€0.2m€0.1m€0.1m▼ 8.9%
Profit (loss) for the period9904€0.8m€0.6m€0.5m€0.5m€0.6m€0.6m€0.4m€0.3m▼ 10.1%
Profit (loss) for the period to be appropriated9905€0.8m€0.6m€0.5m€0.5m€0.6m€0.6m€0.4m€0.3m▼ 10.1%
Line20182019202020212022202320242025Change
Assets
Total assets20/58€1.9m€1.8m€1.8m€1.7m€1.7m€2.6m€3.0m€3.5m▲ 16.9%
Fixed assets21/28€0.07m€0.06m€0.1m€0.08m€0.2m€0.08m€0.06m€0.1m▲ 65.3%
Tangible fixed assets22/27€0.05m€0.05m€0.1m€0.07m€0.1m€0.06m€0.05m€0.09m▲ 84.6%
Plant, machinery and equipment23---€0.07m€0.1m€0.06m€0.05m€0.09m▲ 84.6%
Financial fixed assets28€0.01m€0.01m€0.01m€0.01m€0.01m€0.01m€0.01m€0.01m▲ 0.4%
Current assets29/58€1.8m€1.8m€1.7m€1.6m€1.5m€2.5m€2.9m€3.4m▲ 15.9%
Stocks and contracts in progress3€0.2m€0.2m€0.2m€0.2m€0.2m€0.3m€0.4m€0.9m▲ 102%
Stocks30/36---€0.2m€0.2m€0.3m€0.4m€0.9m▲ 102%
Amounts receivable within one year40/41€0.8m€0.7m€0.6m€0.8m€0.7m€1.0m€1.8m€2.0m▲ 12.2%
Trade receivables40---€0.8m€0.7m€1.0m€0.7m€0.9m▲ 30.1%
Other amounts receivable41---€0.01m€0.01m€0.01m€1.1m€1.1m▲ 0.1%
Cash at bank and in hand54/58€0.9m€0.8m€0.9m€0.5m€0.6m€1.2m€0.7m€0.5m▼ 27.8%
Deferred charges and accrued income490/1---€0.03m€0.005m€0.005m€0.02m€0.004m▼ 77.3%
Equity and liabilities
Total equity and liabilities10/49€1.9m€1.8m€1.8m€1.7m€1.7m€2.6m€3.0m€3.5m▲ 16.9%
Equity10/15€0.8m€0.9m€0.5m€0.6m€1.1m€1.8m€2.1m€2.5m▲ 16.0%
Contributions10/11€0.06m€0.06m€0.06m€0.06m€0.06m€0.06m€0.06m€0.06m=
Capital10---€0.06m€0.06m€0.06m€0.06m€0.06m=
Issued capital100---€0.06m€0.06m€0.06m€0.06m€0.06m=
Reserves13€0.7m€0.8m€0.4m€0.5m€1.1m€1.7m€2.1m€2.4m▲ 16.4%
Non-distributable reserves130/1---€0.006m€0.006m€0.006m€0.006m€0.006m=
Legal reserve130---€0.006m€0.006m€0.006m€0.006m€0.006m=
Distributable reserves133---€0.5m€1.1m€1.7m€2.1m€2.4m▲ 16.5%
Provisions and deferred taxes16€0.05m€0.05m€0.05m€0.05m€0.05m€0.05m€0.05m--
Provisions for liabilities and charges160/5---€0.05m€0.05m€0.05m€0.05m--
Other liabilities and charges164/5---€0.05m€0.05m€0.05m€0.05m--
Amounts payable17/49€1.1m€0.9m€1.3m€1.1m€0.5m€0.8m€0.8m€1.0m▲ 26.0%
Amounts payable within one year42/48€1.1m€0.9m€1.3m€1.1m€0.5m€0.8m€0.8m€1.0m▲ 26.1%
Trade debts44€0.3m€0.3m€0.3m€0.3m€0.3m€0.5m€0.6m€0.8m▲ 41.7%
Suppliers440/4---€0.3m€0.3m€0.5m€0.6m€0.8m▲ 41.7%
Taxes, remuneration and social security45---€0.3m€0.1m€0.3m€0.2m€0.2m▼ 11.3%
Taxes450/3---€0.2m€0.07m€0.2m€0.1m€0.09m▼ 22.0%
Remuneration and social security454/9---€0.1m€0.08m€0.1m€0.1m€0.1m▼ 2.4%
Other amounts payable47/48---€0.4m€0.001m€0.001m€0.001m€0.001m=
Accrued charges and deferred income492/3---€0.004m€0.01m€0.03m€0.005m€0.005m▲ 0.5%
Line20182019202020212022202320242025Change
Profit (loss) for the period9904€781,289€586,729€499,400€490,080€590,228€603,045€378,092€339,858▼ 10.1%
+ Depreciation and write-downs630€43,368€45,508€27,546€20,632€30,174€21,244€19,771€24,455▲ 23.7%
Operating cash flow (approximation)€824,657€632,237€526,946€510,712€620,402€624,289€397,862€364,314▼ 8.4%
Investment in fixed assets (approximation)--€41,628-€74,167€6,373-€110,657€63,124-€2,987-€65,114▼ 2,080%
Change in cash--€66,686€66,530-€349,430€70,391€619,157-€523,831-€193,334▲ 63.1%

A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.

Download as CSV

Historical observation

In July 2024, 31,368 companies had the same profile as BIOMEDICAL DIAGNOSTICS has now. Two years later, 93.5% were still going and 0.5% had gone bankrupt.

  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
93.5% was still going
5.9% stopped otherwise
0.5% went bankrupt

Another 0.1% stopped without a precise date, possibly only after those two years.

That fits the bankruptcy probability of BIOMEDICAL DIAGNOSTICS itself: < 0.1% within 12 months.

Test of the method

The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,368 companies, not a prediction for BIOMEDICAL DIAGNOSTICS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Latest 10 of 22 filings with the National Bank
Financial year Type Filed Reference Document
31-12-2025 full format 19-06-2026 2026-00177557 PDF
31-12-2024 abbreviated format 24-06-2025 2025-00171512 PDF
31-12-2023 abbreviated format 19-06-2024 2024-00142946 PDF
31-12-2022 abbreviated format 26-06-2023 2023-00157278 PDF
31-12-2021 abbreviated format 30-06-2022 2022-20132113 PDF
31-12-2020 abbreviated format 23-07-2021 2021-39000582 PDF
31-12-2019 abbreviated format 09-07-2020 2020-28000383 PDF
31-12-2018 abbreviated format 31-07-2019 2019-41400350 PDF
31-12-2017 abbreviated format 16-07-2018 2018-33700003 PDF
31-12-2016 abbreviated format 14-07-2017 2017-32100317 PDF

Show all 22 filings

Next steps